In the present study, we analyzed the correlation between KLF5 expression and prostate cancer prognosis and examined whether KLF5 downregulation increased cell sensitivity to docetaxel in prostate cancer cells in vitro and in vivo. Here, KLF5 is linked to prostate carcinoma.